TY - JOUR
KW - High dimensional propensity score
KW - confounder adjustment
KW - database research
KW - diagnostics
KW - reporting
AU - J. Tazare
AU - R. Wyss
AU - J. Franklin
AU - L. Smeeth
AU - S. Evans
AU - S. Wang
AU - S. Schneeweiss
AU - I. Douglas
AU - J. Gagne
AU - E. Williamson
AD - Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London.
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Health Data Research (HDR) UK, London.
AN - 35092316
BT - Pharmacoepidemiol Drug Saf
DO - 10.1002/pds.5412
DP - NLM
ET - 2022/01/30
LA - eng
N1 - 1099-1557
Tazare, John
Orcid: 0000-0002-7194-2615
Wyss, Richard
Franklin, Jessica M
Orcid: 0000-0002-8941-4116
Smeeth, Liam
Evans, Stephen J W
Wang, Shirley V
Orcid: 0000-0001-7761-7090
Schneeweiss, Sebastian
Orcid: 0000-0003-2575-467x
Douglas, Ian J
Gagne, Joshua J
Williamson, Elizabeth J
Journal Article
England
Pharmacoepidemiol Drug Saf. 2022 Jan 29. doi: 10.1002/pds.5412.
PY - 2022
SN - 1053-8569
T2 - Pharmacoepidemiol Drug Saf
TI - Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting
ER -